Amneal Pharmaceuticals, Inc. AMRX AvKARE — Goodwill
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Goodwill.
The official record: Amneal Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amneal Pharmaceuticals, Inc.'s avkare — goodwill.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amneal Pharmaceuticals, Inc.'s avkare — goodwill?
- Amneal Pharmaceuticals, Inc. (AMRX) reported avkare — goodwill of $69.47M in Q1 2026.
- How has Amneal Pharmaceuticals, Inc.'s avkare — goodwill changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s avkare — goodwill decreased by 0.0% year-over-year, from $69.47M to $69.47M.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s avkare — goodwill?
- Over 4 years (2021 to 2025), Amneal Pharmaceuticals, Inc.'s avkare — goodwill has grown at a -0.1% compound annual growth rate (CAGR), from $279.5M to $277.86M.
- What does avkare — goodwill mean?
- Reflects the intangible asset value recorded when the AvKARE segment was acquired for a price exceeding the fair market value of its net identifiable assets. It represents the premium paid for brand reputation, customer relationships, and expected future synergies, subject to periodic impairment testing.